ASCO: Overall Survival Up for African - American Men With mCRPC
Improved survival versus Caucasian men treated with docetaxel/prednisone, DP - containing regimen
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Urology, Conference News, Source Type: news
More News: Cancer & Oncology | Conferences | Docetaxel | Prednisone | Taxotere | Urology & Nephrology